title: Economic results of palivizumab prophylaxis using vial sharing on immunisation days.
authors: Fahri
authors: F
authors: Ovalı
authors: Tuğba
authors: T
authors: Gürsoy
authors: Seçil
authors: S
authors: Erçin
authors: Dilek
authors: D
authors: Yavuzcan Öztürk
authors: Hande Özgün
authors: HÖ
authors: Karatepe
authors: Güner
authors: G
authors: Karatekin
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000191:economics*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000191:economics*; D003363:Cost Control / Q000379:methods; D004349:Drug Packaging / Q000191:economics* / Q000379:methods; D006801:Humans; D007114:Immunization / Q000191:economics / Q000379:methods; D007223:Infant; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D014421:Turkey
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab